359 results on '"Pelosi, Giuseppe"'
Search Results
2. Neuroendocrine neoplasms of the lung: a pathology update
3. Navigating resistance to ALK inhibitors in the lorlatinib era: a comprehensive perspective on NSCLC.
4. Head‐to‐head: Should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?
5. Con: "Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible Artifact?".
6. MUC6 distribution in the spectrum of pulmonary mucinous adenocarcinoma
7. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors
8. Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype
9. Bcl-10, trypsin and synaptophysin helps recognize acinar cell and mixed acinar neuroendocrine cell carcinoma of the pancreas on both preoperative cytological samples and needle biopsy specimens
10. Primary MiNEN of the urinary bladder: an hitherto undescribed entity composed of large cell neuroendocrine carcinoma and adenocarcinoma with a distinct clinical behavior: Description of a case and review of the pertinent literature
11. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC
12. Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?
13. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
14. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
15. Morphologic and molecular classification of lung neuroendocrine neoplasms
16. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
17. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
18. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations
19. Molecular Classification of Neuroendocrine Tumors of the Thymus
20. Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth
21. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
22. Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal
23. Coronary artery calcium score is a prognostic factor for mortality in idiopathic pulmonary fibrosis.
24. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung
25. Lung cancer screening with low-dose spiral computed tomography : evidence from a pooled analysis of two Italian randomized trials
26. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases
27. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies
28. A Miniaturized 3-Way Power Divider Based on Bagley Polygon.
29. LETTERS TO THE EDITOR.
30. Immune-related gigantomastia: a case study.
31. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies—reply
32. Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm
33. Diagnosis and management of typical and atypical lung carcinoids
34. Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer
35. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy
36. Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift
37. Distinctive pathological and clinical features of lung carcinoids with high proliferation index
38. Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied
39. Controversial issues and new discoveries in lung neuroendocrine tumors
40. Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study
41. Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis
42. Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules
43. Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer
44. An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer
45. Labeling Lung Neuroendocrine Neoplasms for Ki-67 Antigen to Score a Bull’s-Eye, Not Shoot in the Dark
46. The Natural History in Lung Neuroendocrine Neoplasms: The Stone Guest Who Matters
47. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin‐remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D
48. Considerations on boundary conditions in transformation optics for complete field computation in generic waveguides.
49. Direct synthesis for sequential networks with an arbitrary number of outputs.
50. Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.